Abliva Ab

Abliva AB is a biotechnology company focused on developing innovative treatments for mitochondrial diseases, which are rare genetic disorders caused by dysfunctions in mitochondria. The company's lead product candidates aim to improve the health and quality of life for patients suffering from these debilitating conditions. Abliva's pipeline includes promising therapies targeting the underlying mechanisms of mitochondrial dysfunction, leveraging advanced scientific research and development. With a dedicated team and a commitment to groundbreaking solutions, Abliva strives to address unmet medical needs and contribute to the advancement of mitochondrial disease treatments.